Insulet Corp. (PODD)
PODD Stock Price Chart
Explore Insulet Corp. interactive price chart. Choose custom timeframes to analyze PODD price movements and trends.
PODD Company Profile
Discover essential business fundamentals and corporate details for Insulet Corp. (PODD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 May 2007
Employees
5.40k
Website
https://www.insulet.comCEO
Ashley McEvoy
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
PODD Financial Timeline
Browse a chronological timeline of Insulet Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $1.45, while revenue estimate is $787.42m.
Earnings released on 6 May 2026
EPS came in at $1.42 surpassing the estimated $1.19 by +19.33%, while revenue for the quarter reached $761.70m , beating expectations by +4.36%.
Earnings released on 18 Feb 2026
EPS came in at $1.55 surpassing the estimated $1.47 by +5.44%, while revenue for the quarter reached $783.80m , beating expectations by +1.93%.
Earnings released on 6 Nov 2025
EPS came in at $1.24 surpassing the estimated $1.14 by +8.77%, while revenue for the quarter reached $706.30m , beating expectations by +4.11%.
Earnings released on 7 Aug 2025
EPS came in at $1.17 surpassing the estimated $0.92 by +27.17%, while revenue for the quarter reached $649.10m , beating expectations by +5.68%.
Earnings released on 8 May 2025
EPS came in at $1.02 surpassing the estimated $0.79 by +29.11%, while revenue for the quarter reached $569.00m , beating expectations by +4.73%.
Earnings released on 20 Feb 2025
EPS came in at $1.15 surpassing the estimated $1.00 by +15.00%, while revenue for the quarter reached $597.50m , beating expectations by +2.57%.
Earnings released on 7 Nov 2024
EPS came in at $0.90 surpassing the estimated $0.76 by +18.42%, while revenue for the quarter reached $372.60m , missing expectations by -28.28%.
Earnings released on 8 Aug 2024
EPS came in at $0.55 falling short of the estimated $0.56 by -2.48%, while revenue for the quarter reached $488.50m , beating expectations by +0.10%.
Earnings released on 9 May 2024
EPS came in at $0.73 surpassing the estimated $0.39 by +87.18%, while revenue for the quarter reached $441.70m , beating expectations by +4.16%.
Earnings released on 22 Feb 2024
EPS came in at $1.40 surpassing the estimated $0.66 by +112.12%, while revenue for the quarter reached $509.80m , beating expectations by +10.57%.
Earnings released on 2 Nov 2023
EPS came in at $0.71 surpassing the estimated $0.40 by +77.50%, while revenue for the quarter reached $432.70m , beating expectations by +4.42%.
Earnings released on 8 Aug 2023
EPS came in at $0.38 surpassing the estimated $0.26 by +46.15%, while revenue for the quarter reached $396.50m , beating expectations by +3.00%.
Earnings released on 4 May 2023
EPS came in at $0.23 surpassing the estimated $0.09 by +155.56%, while revenue for the quarter reached $358.10m , beating expectations by +8.24%.
Earnings released on 23 Feb 2023
EPS came in at $0.55 surpassing the estimated $0.24 by +129.17%, while revenue for the quarter reached $369.70m , beating expectations by +11.21%.
Earnings released on 3 Nov 2022
EPS came in at $0.45 surpassing the estimated $0.17 by +164.71%, while revenue for the quarter reached $340.80m , beating expectations by +9.19%.
Earnings released on 4 Aug 2022
EPS came in at -$0.06 falling short of the estimated $0.21 by -128.57%, while revenue for the quarter reached $299.40m , beating expectations by +2.73%.
Earnings released on 5 May 2022
EPS came in at $0.40 surpassing the estimated $0.23 by +73.91%, while revenue for the quarter reached $295.40m , beating expectations by +2.56%.
Earnings released on 23 Feb 2022
EPS came in at $0.42 surpassing the estimated $0.32 by +31.25%, while revenue for the quarter reached $307.70m , beating expectations by +2.79%.
Earnings released on 4 Nov 2021
EPS came in at $0.18 falling short of the estimated $0.24 by -25.00%, while revenue for the quarter reached $275.60m , beating expectations by +1.02%.
Earnings released on 5 Aug 2021
EPS came in at $0.10 falling short of the estimated $0.12 by -16.67%, while revenue for the quarter reached $263.20m , beating expectations by +1.59%.
PODD Stock Performance
Access detailed PODD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
